DV
Dividend Vision

DFTX — Definium Therapeutics, Inc.

Definium Therapeutics, Inc. (DFTX)

Total return is 1163.1% over the past 9.7 years, 847.7 points ahead of SPY at 315.4%. Its deepest 1-year drawdown was 24.8%.

DFTX is an equity stock that operates in the therapeutics sector. The fund does not currently distribute dividends to shareholders and therefore has no yield profile or distribution frequency. This security may appeal primarily to growth-oriented investors seeking exposure to the therapeutic drug development space rather than those focused on generating current income.

DFTX key facts

Asset type
Stock
Asset class
Equity
Inception date
11/15/2016
Distribution frequency
None
Last close
$42.63
Market cap
$5,728,062,976
Average volume
1705200.0
Beta
2.258
Payout ratio
0.0
Forward P/E
0.0
EPS
$-3.43